Autophagy Inhibitor, 3-MA is a synthetic intermediate and a cell-permeable autophagic sequestration blocker that protects cerebellar granule cells from apoptosis post serum/potassium deprivation. Autophagy Inhibitor, 3-MA is a PI 3-kinase p100 (class III PI 3-kinase inhibitor) that displays distinctly different properties from the PI 3-kinase inhibitors LY 294002 (sc-201426) and Wortmannin (sc-3505), in that treatment of cells with 3-MA results in specific redistribution of mannose 6-phosphate/insulin-like growth factor II receptor (MPR300), but does not cause the enlargement of late endosomal/lysosomal compartments. Autophagy Inhibitor, 3-MA is also an inhibitor of PI 3-kinase p110 γ.
1. Caro, L.H., et al. 1988. Eur. J. Biochem. 175: 325-329. PMID: 3402459
2. Eskelinen, E.L., et al. 2002. Traffic. 3: 878-893. PMID: 12453151
3. Beugnet, A., et al. 2003. Biochem. J. 372: 555-566. PMID: 12611592
4. Hirosako, K., et al. 2004. Biochem. Biophys. Res. Commun. 316: 845-852. PMID: 15033478
5. Canu, N., et al. 2005. J. Neurochem. 92: 1228-1242. PMID: 15715672
See how others have used Autophagy Inhibitor, 3-MA. Click on the entry to view the PubMed entry .
PMID: # 28288862
Fan, C. et al. 2017. Autophagy inhibits C2-ceramide-mediated cell death by decreasing the reactive oxygen species levels in SH-SY5Y cells. Neurosci. Lett.. 651: 198-206.
PMID: # 28212571
Lee, J. et al. 2017. Activation of JNK and IRE1 is critically involved in tanshinone I-induced p62 dependent autophagy in malignant pleural mesothelioma cells: implication of p62 UBA domain. Oncotarget. 8: 25032-25045.
PMID: # 28968601
Fan, B. et al. 2017. Fangchinoline Induces Apoptosis, Autophagy and Energetic Impairment in Bladder Cancer. Cell. Physiol. Biochem.. 43: 1003-1011.
PMID: # 28435516
D'Eliseo, D. et al. 2017. Docosahexaenoic acid (DHA) promotes immunogenic apoptosis in human multiple myeloma cells, induces autophagy and inhibits STAT3 in both tumor and dendritic cells. Genes Cancer. 8: 426-437.
PMID: # 28238714
Hu, X. et al. 2017. Neuroprotective effects of Kukoamine A on neurotoxin-induced Parkinson's model through apoptosis inhibition and autophagy enhancement. Neuropharmacology. 117: 352-363.
PMID: # 28499910
Aseer, KR. et al. 2017. SPARC paucity alleviates superoxide-mediated oxidative stress, apoptosis, and autophagy in diabetogenic hepatocytes. Free Radic. Biol. Med.. 108: 874-895.
PMID: # 27551491
Xia, XJ. et al. 2016. Autophagy mediated by arginine depletion activation of the nutrient sensor GCN2 contributes to interferon-γ-induced malignant transformation of primary bovine mammary epithelial cells. Cell Death Discov. 2: 15065.
PMID: # 26031379
Sun, L. et al. 2015. A novel cognitive impairment mechanism that astrocytic p-connexin 43 promotes neuronic autophagy via activation of P2X7R and down-regulation of GLT-1 expression in the hippocampus following traumatic brain injury in rats. Behav. Brain Res.. 291: 315-24.
PMID: # 26486079
2015. CGK733-induced LC3 II formation is positively associated with the expression of cyclin-dependent kinase inhibitor p21Waf1/Cip1 through modulation of the AMPK and PERK/CHOP signaling pathways. Oncotarget. 6: 39692-701.
PMID: # 26316755
Cai, Z. et al. 2015. Autophagy dysfunction upregulates beta-amyloid peptides via enhancing the activity of γ-secretase complex. Neuropsychiatr Dis Treat. 11: 2091-9.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2018 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.